Vitamin E TPGS as a molecular biomaterial for drug delivery
The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Parhi, P., Mohanty, C., & Sahoo, S. K. (2011) · Acta Biomaterialia · doi:10.1016/j.actbio.2011.06.015 · Cited by 14
RetractedThe dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
Feng, S.-S. (2006) · Nanomedicine · doi:10.2217/17435889.1.3.297 · Cited by 1,951
Self-citationYin Win, K., & Feng, S.-S. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.07.050 · Cited by 1,452
Self-citationEffective drug delivery by PEGylated drug conjugates
Greenwald, R. B., Choe, Y. H., McGuire, J., & Conover, C. D. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00180-1 · Cited by 869
Mu, L., & Feng, S. S. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00320-6 · Cited by 725
Self-citationHPMA copolymer–anticancer drug conjugates: design, activity, and mechanism of action
Kopecek, J. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00075-8 · Cited by 562
Dong, Y., & Feng, S.-S. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.09.055 · Cited by 468
Self-citationPolylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents
Dinarvand, R., Sepehri, N., Manouchehri, Rouhani, & Atyabi, F. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s18905 · Cited by 453
Inhibition of P-Glycoprotein by D-α-Tocopheryl Polyethylene Glycol 1000 Succinate (TPGS)
Dintaman, J. M., & Silverman, J. A. (1999) · Pharmaceutical Research · doi:10.1023/a:1015000503629 · Cited by 426
Cited by
siRNA versus miRNA as therapeutics for gene silencing
Lam, J. K. W., Chow, M. Y. T., Zhang, Y., & Leung, S. W. S. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.23 · Cited by 1,081
Muthu, M. S., Leong, D. T., Mei, L., & Feng, S.-S. (2014) · Theranostics · doi:10.7150/thno.8698 · Cited by 603
Self-citationXu, W., Ling, P., & Zhang, T. (2013) · Journal of Drug Delivery · doi:10.1155/2013/340315 · Cited by 595
“Furthermore, its unique physicochemical properties (high water solubility, high flexibility, and large exclusion volume) provide good “stealth” properties for PMs [65, 66], while poly(N-vinyl-2-pyrrolidone) (PVP) [67] and poly(acrylic acid) (PAA) [68] are frequently used as PEG alternatives.”
BackgroundInfluentialThe applications of Vitamin E TPGS in drug delivery
Guo, Y., Luo, J., Tan, S., Otieno, B. O., & Zhang, Z. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.02.006 · Cited by 523
Self-citationCore–shell-type lipid–polymer hybrid nanoparticles as a drug delivery platform
Mandal, B., Bhattacharjee, H., Mittal, N., Sah, H., Balabathula, P., Thoma, L. A., & Wood, G. C. (2013) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2012.11.010 · Cited by 467
Recent Advances in the Application of Vitamin E TPGS for Drug Delivery
Yang, C., Wu, T., Qi, Y., & Zhang, Z. (2018) · Theranostics · doi:10.7150/thno.22711 · Cited by 402
Self-citationPharmaceutical nanotechnology for oral delivery of anticancer drugs
Mei, L., Zhang, Z., Zhao, L., Huang, L., Yang, X.-L., Tang, J., & Feng, S.-S. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.11.005 · Cited by 373
Self-citationPolymeric micelles: nanocarriers for cancer-targeted drug delivery
Zhang, Y., Huang, Y., & Li, S. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0113-z · Cited by 367
Zeng, X., Tao, W., Mei, L., Huang, L., Tan, C., & Feng, S.-S. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.04.052 · Cited by 282
Self-citationStabilizing Agents for Drug Nanocrystals: Effect on Bioavailability
Tuomela, A., Hirvonen, J., & Peltonen, L. (2016) · Pharmaceutics · doi:10.3390/pharmaceutics8020016 · Cited by 282
Tian, G., Zhang, X., Gu, Z., & Zhao, Y. (2015) · Advanced Materials · doi:10.1002/adma.201503280 · Cited by 278
Cheng, W., Liang, C., Xu, L., Liu, G., Gao, N., Tao, W., Luo, L., Zuo, Y., Wang, X., Zhang, X., et al. (2017) · Small · doi:10.1002/smll.201700623 · Cited by 269
Micro and nanoscale technologies in oral drug delivery
Ahadian, S., Finbloom, J. A., Mofidfar, M., Diltemiz, S. E., Nasrollahi, F., Davoodi, E., Hosseini, V., Mylonaki, I., Sangabathuni, S., Montazerian, H., et al. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.012 · Cited by 268
Vitamin E-based nanomedicines for anti-cancer drug delivery
Duhem, N., Danhier, F., & Préat, V. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.009 · Cited by 253
Poloxamer 407/TPGS mixed micelles as promising carriers for cyclosporine ocular delivery
Grimaudo, M. A., Pescina, S., Padula, C., Santi, P., Concheiro, A., Alvarez-Lorenzo, C., & Nicoli, S. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00939 · Cited by 138
Trackable Mitochondria-Targeting Nanomicellar Loaded with Doxorubicin for Overcoming Drug Resistance
Zhang, Y., Zhang, C., Chen, J., Liu, L., Hu, M., Li, J., & Bi, H. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b07219 · Cited by 109
Docetaxel-loaded folate-modified TPGS-transfersomes for glioblastoma multiforme treatment
Luiz, M. T., Viegas, J. S. R., Abriata, J. P., Tofani, L. B., Vaidergorn, M. D. M., Emery, F. D. S., Chorilli, M., & Marchetti, J. M. (2021) · Materials Science and Engineering: C · doi:10.1016/j.msec.2021.112033 · Cited by 62
Vadlapudi, A. D., Cholkar, K., Vadlapatla, R. K., & Mitra, A. K. (2014) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2013.0157 · Cited by 62
Li, Y., Li, R., Liu, Q., Li, W., Zhang, T., Zou, M., Li, H., Wu, T., Cheng, S., Su, Z., et al. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00712 · Cited by 16
Self-citationSathe, P., Nagarjuna, V., Sharma, H., Velpandian, T., Garg, P., & Nirmal, J. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00423 · Cited by 3
Metadata
- Authors
- Zhang, Z., Tan, S., & Feng, S.-S.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2012-06
- Volume
- 33
- Issue
- 19
- Pages
- 4889-4906
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2060265857
- Cited by
- 586
- References
- 98
- FWCI
- 15.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.